Latest Research in Lung Cancer Treatments and Mutations

Top Research Topics in Lung Cancer Treatments and Mutations

• Lung Cancer Treatments and Mutations — 21 papers
• Breast Cancer Treatment Studies — 10 papers
• Cancer Immunotherapy and Biomarkers — 9 papers
• Bladder and Urothelial Cancer Treatments — 9 papers
• Advanced Breast Cancer Therapies — 6 papers
• Cancer Risks and Factors — 5 papers
• BRCA gene mutations in cancer — 3 papers
• Radiomics and Machine Learning in Medical Imaging — 2 papers
• HER2/EGFR in Cancer Research — 2 papers
• Head and Neck Cancer Studies — 2 papers

Highest-Cited Papers

1. Genomic landscape of papillary thyroid carcinoma in Kuwait reveals novel candidate somatic variants
2. MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis
3. Phase III Trials Test First-Line Options in Advanced NSCLC
4. SURVIVAL ANALYSIS OF BREAST CANCER PATIENTS USING CLINICAL RISK PARAMETERS: A STATISTICAL APPROACH BASED ON TIME-TO-EVENT MODELLING
5. Immunotherapy with Pembrolizumab beyond Progression and Local Ablative Therapy in Oligoprogressive metastatic NSCLC.
6. Incidence and risk factors for pneumonitis in urothelial carcinoma treated with enfortumab vedotin plus pembrolizumab: retrospective study
7. Landmark Analysis and HER2 ‐Stratified Validation in the IHC4 ‐Associated Radiomic Model
8. Clinicopathological profile of ALK and ROS1-positive lung tumors: a single-centre retrospective study from Nepal
9. Evaluation of MET Detection Methods and Cutoffs in EGFR-Mutated Non-small Cell Lung Cancer Following Disease Progression on Osimertinib in the phase II SAVANNAH study
10. Estimated Acquisition Cost Differences between Fixed and Simulated Body Weight-Based Nivolumab Dosing Using Real-World Claims Data in Japan
11. Development of a Consensus-Based Risk Stratification Algorithm for HR+/HER2− Early Breast Cancer to Guide Adjuvant CDK4/6i Therapy: Outcomes from a Multidisciplinary Workshop in India
12. Immunohistochemical profiling of the tumor microenvironment in Ethiopian breast cancer tissue: insights into pathology and subtypes
13. Pembrolizumab plus chemotherapy as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: 4.5-year follow-up from the randomized phase III KEYNOTE-859 study
14. EGFR Mutation Subtype and Risk of Brain Metastases From Non–Small Cell Lung Cancer in the Osimertinib Era
15. Artificial intelligence-based integration of imaging, exposome, and multi-omics data for immune-related biomarker discovery and precision prevention in breast cancer
16. Genomic biomarkers of ipatasertib response in patients with hormone receptor-positive metastatic breast cancer
17. Disitamab vedotin combined with PD-1 inhibitors for postoperative adjuvant therapy in upper tract urothelial carcinoma: a retrospective exploratory case series
18. Evaluation of an AI-based digital pathology tool for breast cancer recurrence risk
19. Immunotherapy for Triple-Negative Breast Cancer: Disparities in Access and Opportunities for Equity
20. Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy